HEALTH● LOWJun 23 · Jun 23, 2026, 11:34 AM
AbbVie, Enanta announce EU label expansion for hepatitis C therapy, Maviret
Seeking Alpha Tech
AbbVie and Enanta have announced an EU label expansion for their hepatitis C therapy, Maviret. This expansion broadens the approved usage of the drug in the European Union.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH33m agoBarbie Simons remembered her father Leonardo Simons 30 years after his death: "The worst day of my life"ClarínHEALTH1h agoThe average hospital stay is getting more expensive , new survey findsfox17online.com · United StatesHEALTH1h ago It will impact everyone . UW faculty warn new federal student loan limits could strain health , social serviceskuow.org · United StatesHEALTH3h agoHit a midlife wall? This test identifies your strengths and what matters to youNPR News